Tanvir Bajwa, Guilherme F Attizzani, Hemal Gada, Stanley J Chetcuti, Mathew R Williams, Mustafa Ahmed, George A Petrossian, Matthew D Saybolt, Suhail Q Allaqaband, William M Merhi, Robert C Stoler, Hiram Bezerra, Paul Mahoney, Willis Wu, Robert Jumper, Larry Lambrecht, Gilbert H L Tang
BACKGROUND: The next generation supra-annular, self-expanding Evolut FX transcatheter aortic valve (TAV) system was designed to improve catheter deliverability, provide stable and symmetric valve deployment, and assess commissural alignment during the procedure. The impact of these modifications has not been clinically evaluated. METHODS: Procedural information was collected by survey in 2 Stages: Stage I comprised 23 centers with extensive experience with Evolut TAV systems, and Stage II comprised an additional 46 centers with a broad range of balloon- and self-expanding system experience...
April 7, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions